{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:11:28Z","timestamp":1790266288174,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"L\u2019Agence de la Biom\u00e9decine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is concern about the impact of immunosuppressive agents taken by male kidney transplant (KT) recipients on the risk of foetal malformations. The aim of our survey was to estimate the paternity rate and the outcomes of pregnancies fathered by kidney transplanted males.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This survey analysed 1332 male KT recipients older than 18\u2009years, followed in 13 centres in France. A self-reported questionnaire was used to collect data on the patients, treatments at the time of conception and the pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included data on 349 children from 404 pregnancies fathered by 232 male KT recipients. The paternity rate was 17% (95% CI [15\u201320]). There were 37 (9%, 95% CI [7\u201312]) spontaneous abortions, 12 (3%, 95% CI [2\u20135]) therapeutic abortions, 2 (0.5%, 95% CI [0.1\u20131]) still births, and 13 (4%, 95% CI [2\u20136]) malformations reported. Compared to the general population, there was no difference in the proportion of congenital malformations nor unwanted outcomes whether the father was exposed or not to immunosuppressive agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This survey does not provide any warning signal that pregnancies fathered by male patients exposed to immunosuppressive agents, notably the debated MMF\/MPA, have more complications than pregnancies in the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-02115-x","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:06:22Z","timestamp":1605503182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study"],"prefix":"10.1186","volume":"21","author":[{"name":"On behalf of the Spiesser transplant group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-9648","authenticated-orcid":false,"given":"Annabel","family":"Boyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lobbedez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ouethrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Thuillier Lecouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Ch\u00e2telet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hurault de Ligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"2115_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM196308152690704","volume":"269","author":"JE Murray","year":"1963","unstructured":"Murray JE, Reid DE, Harrison JH, Merrill JP. Successful pregnancies after human renal transplantation. N Engl J Med. 1963;269:341\u20133.","journal-title":"N Engl J Med"},{"key":"2115_CR2","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1111\/j.1600-6143.2011.03656.x","volume":"11","author":"NA Deshpande","year":"2011","unstructured":"Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Montgomery RA, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11:2388\u2013404.","journal-title":"Am J Transplant"},{"key":"2115_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/01.tp.0000263357.44975.d0","volume":"83","author":"N Sibanda","year":"2007","unstructured":"Sibanda N, Briggs JD, Davison JM, Johnson RJ, Rudge CJ. Pregnancy after organ transplantation: a report from the UK transplant pregnancy registry. Transplantation. 2007;83:1301\u20137.","journal-title":"Transplantation."},{"key":"2115_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.trre.2008.05.001","volume":"22","author":"VT Armenti","year":"2008","unstructured":"Armenti VT, Constantinescu S, Moritz MJ, Davison JM. Pregnancy after transplantation. Transplant Rev. 2008;22:223\u201340.","journal-title":"Transplant Rev"},{"key":"2115_CR5","unstructured":"Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR, et al. Report from the national transplantation pregnancy registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2010;7:65\u201385."},{"key":"2115_CR6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.bpobgyn.2014.07.020","volume":"28","author":"LA Coscia","year":"2014","unstructured":"Coscia LA, Constantinescu S, Davison JM, Moritz MJ, Armenti VT. Immunosuppressive drugs and fetal outcome. Best Pract Res Clin Obstet Gynaecol. 2014;28:1174\u201387.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2115_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJMra050431","volume":"354","author":"DB McKay","year":"2006","unstructured":"McKay DB, Josephson MA. Pregnancy in recipients of solid organs--effects on mother and child. N Engl J Med. 2006;354:1281\u201393.","journal-title":"N Engl J Med"},{"key":"2115_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1341-8076.2003.00106.x","volume":"29","author":"JM Davison","year":"2003","unstructured":"Davison JM, Bailey DJ. Pregnancy following renal transplantation. J Obstet Gynaecol Res. 2003;29:227\u201333.","journal-title":"J Obstet Gynaecol Res"},{"key":"2115_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1471-0528.2005.00607.x","volume":"112","author":"B Kallen","year":"2005","unstructured":"Kallen B, Westgren M, Aberg A, Olausson PO. Pregnancy outcome after maternal organ transplantation in Sweden. BJOG. 2005;112:904\u20139.","journal-title":"BJOG."},{"key":"2115_CR10","first-page":"1036","volume":"25","author":"VT Armenti","year":"1993","unstructured":"Armenti VT, Ahlswede BA, Moritz MJ, Jarrell BE. National transplantation pregnancy registry: analysis of pregnancy outcomes of female kidney recipients with relation to time interval from transplant to conception. Transplant Proc. 1993;25:1036\u20137.","journal-title":"Transplant Proc"},{"key":"2115_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12882-019-1213-5","volume":"20","author":"S Shah","year":"2019","unstructured":"Shah S, Venkatesan RL, Gupta A, Sanghavi MK, Welge J, Johansen R, et al. Pregnancy outcomes in women with kidney transplant: metaanalysis and systematic review. BMC Nephrol. 2019;20:24.","journal-title":"BMC Nephrol"},{"key":"2115_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","volume":"82","author":"NM Sifontis","year":"2006","unstructured":"Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006;82:1698\u2013702.","journal-title":"Transplantation."},{"key":"2115_CR13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/ajmg.a.32685","volume":"149A","author":"MT Anderka","year":"2009","unstructured":"Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A. 2009;149A:1241\u20138.","journal-title":"Am J Med Genet A"},{"key":"2115_CR14","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.transproceed.2009.03.088","volume":"41","author":"MF Dei Malatesta","year":"2009","unstructured":"Dei Malatesta MF, Rocca B, Gentile T, Hadjistilianou T, Borri M, de Francesco S, et al. A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. Transplant Proc. 2009;41:1407\u20139.","journal-title":"Transplant Proc"},{"key":"2115_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ajmg.a.35223","volume":"158A","author":"M Hoeltzenbein","year":"2012","unstructured":"Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European network of teratology information services. Am J Med Genet A. 2012;158A:588\u201396.","journal-title":"Am J Med Genet A"},{"key":"2115_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/01.AOG.0000124986.32858.ba","volume":"103","author":"C Le Ray","year":"2004","unstructured":"Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol. 2004;103:1091\u20134.","journal-title":"Obstet Gynecol"},{"key":"2115_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.32117","volume":"146A","author":"A Perez-Aytes","year":"2008","unstructured":"Perez-Aytes A, Ledo A, Boso V, S\u00e1enz P, Roma E, Poveda JL, et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet A. 2008;146A:1\u20137.","journal-title":"Am J Med Genet A"},{"key":"2115_CR18","unstructured":"FDA. CellCept. Drug label information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/050722s015,050723s012,050758s013,050759s018lbl.pdf. Published 2007. Accessed 7 May 2020."},{"key":"2115_CR19","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/j.1600-6143.2005.00969.x","volume":"5","author":"DB McKay","year":"2005","unstructured":"McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, et al. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005;5:1592\u20139.","journal-title":"Am J Transplant"},{"key":"2115_CR20","first-page":"50","volume":"17 Suppl 4","author":"EBPG Expert Group on Renal Transplantation","year":"2002","unstructured":"EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant. 2002;17 Suppl 4:50\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"2115_CR21","doi-asserted-by":"crossref","unstructured":"Le HL, Francke M, Andrews LM, De Winter BCM, Van Gelder T, Hesselink DA. Usage of Tacrolimus and Mycophenolic acid during conception, pregnancy and lactation, and its implications for therapeutic drug monitoring: a systematic critical review. Ther Drug Monit. 2020;42(4):518\u201331.","DOI":"10.1097\/FTD.0000000000000769"},{"key":"2115_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7182\/pit2013636","volume":"23","author":"A Jones","year":"2013","unstructured":"Jones A, Clary MJ, McDermott E, Coscia LA, Constantinescu S, Moritz MJ, et al. Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products. Prog Transplant. 2013;23:153\u20137.","journal-title":"Prog Transplant"},{"key":"2115_CR23","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/ajt.13159","volume":"15","author":"NH Morken","year":"2015","unstructured":"Morken NH, Diaz-Garcia C, Reisaeter AV, Foss A, Leivestad T, Geiran O, et al. Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation. Am J Transplant. 2015;15:1666\u201373.","journal-title":"Am J Transplant"},{"key":"2115_CR24","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1097\/TP.0000000000001747","volume":"101","author":"K Midtvedt","year":"2017","unstructured":"Midtvedt K, Bergan S, Reisaeter AV, Vikse BE, Asberg A. Exposure to mycophenolate and fatherhood. Transplantation. 2017;101:e214\u20137.","journal-title":"Transplantation."},{"key":"2115_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11255-009-9644-8","volume":"42","author":"Y Boobes","year":"2010","unstructured":"Boobes Y, Bernieh B, Saadi H, Raafat Al Hakim M, Abouchacra S. Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus. Int Urol Nephrol. 2010;42:493\u20138.","journal-title":"Int Urol Nephrol"},{"key":"2115_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1432-2277.2006.00423.x","volume":"20","author":"E Huyghe","year":"2007","unstructured":"Huyghe E, Zairi A, Nohra J, Kamar N, Plante P, Rostaing L. Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview. Transpl Int. 2007;20:305\u201311.","journal-title":"Transpl Int"},{"key":"2115_CR27","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.transproceed.2005.04.004","volume":"37","author":"V Tondolo","year":"2005","unstructured":"Tondolo V, Citterio F, Panocchia N, Nanni G, Favi E, Brescia A, et al. Gonadal function and immunosuppressive therapy after renal transplantation. Transplant Proc. 2005;37:1915\u20137.","journal-title":"Transplant Proc"},{"key":"2115_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1439-0272.2007.00787.x","volume":"39","author":"J Skrzypek","year":"2007","unstructured":"Skrzypek J, Krause W. Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment. Andrologia. 2007;39:198\u20139.","journal-title":"Andrologia."},{"key":"2115_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1600-6143.2008.02267.x","volume":"8","author":"J Zuber","year":"2008","unstructured":"Zuber J, Anglicheau D, Elie C, Bererhi L, Timsit M-O, Mamzer-Bruneel M-F, et al. Sirolimus may reduce fertility in male renal transplant recipients. Am J Transplant. 2008;8:1471\u20139.","journal-title":"Am J Transplant"},{"key":"2115_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.reprotox.2015.10.015","volume":"58","author":"AR Scialli","year":"2015","unstructured":"Scialli AR, Bailey G, Beyer BK, B\u00f8gh IB, Breslin WJ, Chen CL, et al. Potential seminal transport of pharmaceuticals to the conceptus. Reprod Toxicol. 2015;58:213\u201321.","journal-title":"Reprod Toxicol"},{"key":"2115_CR31","unstructured":"Roche. Mycophenolate mofetil (CellCept): serious risk of teratogenicity - important new pregnancy prevention advice for women and men. https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwiovqix_froAhWyZDUKHfZiDGkQFjAAegQIARAB&url=https%3A%2F%2Fwww.hpra.ie%2Fdocs%2Fdefault-source%2Fdefault-document-library%2Fimportant-safety-information%2D%2D-cellcept-(mycophenolate-mofetil).pdf%3Fsfvrsn%3D0&usg=AOvVaw3LM_4Orwhg4O51nfbRVwLA. Published 2015. Accessed 7 May 2020."},{"key":"2115_CR32","unstructured":"European Medicines Agency. EMA recommends additional measures to prevent use of mycophenolate in pregnancy. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/. Published 2015. Accessed 7 May 2020."},{"key":"2115_CR33","unstructured":"ANSM. Mycoph\u00e9nolate (Cellcept\u00ae et g\u00e9n\u00e9riques et Myfortic\u00ae) : nouvelles contre-indications et mesures de pr\u00e9vention de la grossesse en raison du risque important de t\u00e9ratog\u00e9nicit\u00e9 - Point d\u2019Information. https:\/\/www.ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Mycophenolate-Cellcept-R-et-generiques-et-Myfortic-R-nouvelles-contre-indications-et-mesures-de-prevention-de-la-grossesse-en-raison-du-risque-important-de-teratogenicite-Point-d-Information. Published 2015. Accessed 7 May 2020."},{"key":"2115_CR34","unstructured":"Anonymous. Mycophenolate: updated recommendations for contraception men and women. https:\/\/www.ema.europa.eu\/en\/news\/mycophenolate-updated-recommendations-contraception-men-women. Published 2018. Accessed 7 May 2020."},{"key":"2115_CR35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/bdra.23556","volume":"106","author":"P Damkier","year":"2016","unstructured":"Damkier P, Passier A, Bo Petersen L, Havnen G, Thestrup Pedersen AJ. Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: an unnecessary and insufficiently substantiated precaution. Birth Defects Res A Clin Mol Teratol. 2016;106:860\u20131.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2115_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001509","volume":"101","author":"K Midtvedt","year":"2017","unstructured":"Midtvedt K, Asberg A. Mycophenolate acid and balancing the risk for male allograft recipients. Transplantation. 2017;101:e39.","journal-title":"Transplantation."},{"key":"2115_CR37","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/TP.0000000000001342","volume":"100","author":"DR Kuypers","year":"2016","unstructured":"Kuypers DR, Van Mieghem T, Meijers B, Claes K. Updated manufacturer and European medicines agency recommendations on the use of mycophenolate acid: balancing the risks for male allograft recipients. Transplantation. 2016;100:e50\u20131.","journal-title":"Transplantation."},{"key":"2115_CR38","unstructured":"Transplant Pregnancy Registry International. A division of gift of life institute. https:\/\/www.transplantpregnancyregistry.org\/participation\/. Accessed 7 May 2020."},{"key":"2115_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJM197706022962201","volume":"296","author":"S Holdsworth","year":"1977","unstructured":"Holdsworth S, Atkins RC, de Kretser DM. The pituitary-testicular axis in men with chronic renal failure. N Engl J Med. 1977;296:1245\u20139.","journal-title":"N Engl J Med"},{"key":"2115_CR40","first-page":"144","volume":"22","author":"DJ Handelsman","year":"1984","unstructured":"Handelsman DJ, McDowell IF, Caterson ID, Tiller DJ, Hall BM, Turtle JR. Testicular function after renal transplantation: comparison of Cyclosporin a with azathioprine and prednisone combination regimes. Clin Nephrol. 1984;22:144\u20138.","journal-title":"Clin Nephrol"},{"key":"2115_CR41","unstructured":"INSERM. Infertilit\u00e9, des difficult\u00e9s \u00e0 concevoir d\u2019origines multiples. https:\/\/www.inserm.fr\/information-en-sante\/dossiers-information\/infertilite. Accessed 7 May 2020."},{"key":"2115_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12958-015-0032-1","volume":"13","author":"A Agarwal","year":"2015","unstructured":"Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37.","journal-title":"Reprod Biol Endocrinol"},{"key":"2115_CR43","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s10815-018-1301-7","volume":"35","author":"O Okutman","year":"2018","unstructured":"Okutman O, Rhouma MB, Benkhalifa M, Muller J, Viville S. Genetic evaluation of patients with non-syndromic male infertility. J Assist Reprod Genet. 2018;35:1939\u201351.","journal-title":"J Assist Reprod Genet"},{"key":"2115_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.beem.2010.08.006","volume":"25","author":"C Krausz","year":"2011","unstructured":"Krausz C. Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab. 2011;25:271\u201385.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2115_CR45","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jgyn.2014.09.011","volume":"43","author":"A Delabaere","year":"2014","unstructured":"Delabaere A, Huchon C, Deffieux X, Beucher G, Gallot V, Nedellec S, et al. Epidemiology of loss pregnancy. J Gynecol Obstet Biol Reprod. 2014;43:764\u201375.","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"2115_CR46","unstructured":"Agence de la Biom\u00e9decine. Rapport d\u2019activit\u00e9 annuel des centres pluridisciplinaires de diagnostic pr\u00e9natal 2015. https:\/\/www.agence-biomedecine.fr\/annexes\/bilan2016\/donnees\/diag-prenat\/02-centres\/pdf\/cpdpn.pdf. Accessed 7 May 2020."},{"key":"2115_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/1471-0528.14767","volume":"125","author":"B Blondel","year":"2018","unstructured":"Blondel B, Cuttini M, Hindori-Mohangoo AD, Gissler M, Loghi M, Prunet C, et al. How do late terminations of pregnancy affect comparisons of stillbirth rates in Europe? Analyses of aggregated routine data from the euro-Peristat project. Bjog. 2018;125:226\u201334.","journal-title":"Bjog."},{"key":"2115_CR48","unstructured":"INSERM et DRESS. Enqu\u00eate nationale p\u00e9rinatale Rapport 2016. Les naissances et les \u00e9tablissements Situation et \u00e9volution depuis 2010. http:\/\/www.xn--epop-inserm-ebb.fr\/wp-content\/uploads\/2017\/10\/ENP2016_rapport_complet.pdf. Published 2017. Accessed 7 May 2020."},{"key":"2115_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194986","volume":"13","author":"JK Morris","year":"2018","unstructured":"Morris JK, Springett AL, Greenlees R, Loane M, Addor M-C, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012. PLoS One. 2018;13:e0194986.","journal-title":"PLoS One"},{"key":"2115_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1891\/0730-0832.37.4.197","volume":"37","author":"R Galea","year":"2018","unstructured":"Galea R, Said E. Infantile hypertrophic pyloric stenosis: an epidemiological review. Neonatal Netw. 2018;37:197\u2013204.","journal-title":"Neonatal Netw"},{"key":"2115_CR51","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.arcped.2005.02.029","volume":"12","author":"J Br\u00e9aud","year":"2005","unstructured":"Br\u00e9aud J, Guys JM. Phimosis: medical treatment or circumcision? Arch Pediatrie. 2005;12:1424\u201332.","journal-title":"Arch Pediatrie"},{"key":"2115_CR52","volume-title":"Wolff Parkinson white syndrome (WPW)","author":"L Chhabra","year":"2020","unstructured":"Chhabra L, Goyal A, Benham M. Wolff Parkinson white syndrome (WPW). Treasure Island, FL: StatPearls Publishing; 2020."},{"key":"2115_CR53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0035-1556743","volume":"4","author":"LA Coscia","year":"2015","unstructured":"Coscia LA, Armenti DP, King RW, Sifontis NM, Constantinescu S, Moritz MJ. Update on the teratogenicity of maternal mycophenolate mofetil. J Pediatr Genet. 2015;4:42\u201355.","journal-title":"J Pediatr Genet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02115-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-02115-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02115-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:16:54Z","timestamp":1605503814000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02115-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2115"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02115-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-52614\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-52614\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of CHU de Caen (France) and was conducted according to the declaration of Helsinki. Informed and written consent to participate in the study was obtained from participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"483"}}